Sunday February 23, 2020

Merrion Pharmaceuticals announces liquidation plan

Company could have around €4.5m to distribute to shareholders

22nd August, 2016
Dr John Fox to leave Merrion Pharmaceuticals after EGM. PIcture: Feargal Ward

The board of Dublin-listed Merrion Pharmaceuticals has proposed that the company be wound up, with its remaining funds distributed to shareholders.

In a statement today, however, Merrion said its board had looked at a number of investment proposals, none of which were thought "sufficiently compelling" to recommend to shareholders.

The board said a statutory declaration of solvency for the company indicated that around €4.5m was available to shareholders from the proposed liquidation, though this figure...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The narrative of the Sinn Féin surge suggests that politics in Ireland is becoming more polarised like in the US and Britain, but the reality is far more complex

Colin Murphy | 1 week ago

Bank chief McDonagh says move would create better work environment for young parents and people with caring responsibilities

Killian Woods | 1 week ago

Despite a belated show of independence, the US attorney general has been a willing pawn in Trump’s interference in criminal investigations being carried out by the Department of Justice

Marion McKeone | 1 week ago